Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2019 Nov;41(8):606–611. doi: 10.1097/MPH.0000000000001477

TABLE 1.

Treatment by Gender and Age Category

Treatment Category Gender Frequency (Column %)
Female Male Total
Ages: 4.0–7.9 years
HU 16 (21.0%) 19 (23.5%) 35 (22.2%)
No therapy 52 (68.4%) 53 (65.4%) 105 (66.9%)
Transfusion 8 (10.5%) 9 (11.1%) 17 (10.8%)
Total 76 81 157
Ages 8.0–12.0
HU 28 (36.8%) 34 (42.0%) 62 (39.5%)
No therapy 35 (46.0%) 32 (39.5%) 67 (42.7%)
Transfusion 13 (17.1%) 15 (18.5%) 28 (17.8%)
Total 76 81 157

HU: Hydroxyurea